Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis.
Merve Bahar ErcanBelgin KocerTaylan AltıparmakIlker ArslanPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2024)